Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
9 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Instil Bio, Inc.’s names, not what it holds today.
Patents granted
9
9 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 3 in 2024 and 4 in 2023
Applications published
25
1 of them in 2025
Names they are printed under
5
a subsidiary, its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology8
Medical technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name5 counted
INSTIL BIO (UK) LIMITED a subsidiary
named as the applicant on its applications, in GB. 1 more under the same name are not counted (printed in UK)
17 publishedINSTIL BIO (UK) LIMITED a subsidiary
GB, as the owner printed on each patent
1 publishedInstil Bio, Inc. its own name
named as the applicant on its applications, in US
3 publishedInstil Bio, Inc. its own name
US, as the owner printed on each patent
3 publishedCELLULAR THERAPEUTICS LTD a subsidiary
named as the applicant on its applications, in GB
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jan 7, 2025 | 12,187,778 | Receptors providing targeted costimulation for adoptive cell therapy | Biotechnology | INSTIL BIO (UK) LIMITED |
| Dec 24, 2024 | 12,173,271 | Aseptic tissue processing method, kit and device | Biotechnology | INSTIL BIO (UK) LIMITED |
| Oct 15, 2024 | 12,116,564 | Cells expressing recombinant growth factor receptors | Biotechnology | INSTIL BIO (UK) LIMITED |
| Apr 2, 2024 | 11,945,876 | Receptors providing targeted costimulation for adoptive cell therapy | Biotechnology | INSTIL BIO (UK) LIMITED |
| Sep 26, 2023 | 11,767,510 | Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof | Medical technology | INSTIL BIO (UK) LIMITED |
| Jul 11, 2023 | 11,697,677 | Chimeric molecules providing targeted costimulation for adoptive cell therapy | Biotechnology | INSTIL BIO (UK) LIMITED |
| Apr 4, 2023 | 11,618,878 | Aseptic tissue processing method, kit and device | Biotechnology | INSTIL BIO (UK) LIMITED |
| Apr 4, 2023 | 11,618,877 | Aseptic tissue processing method, kit and device | Biotechnology | INSTIL BIO (UK) LIMITED |
| Dec 20, 2022 | 11,530,386 | Cells expressing recombinant growth factor receptors | Biotechnology | INSTIL BIO (UK) LIMITED |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Feb 6, 2025 | 2025/0041342 | PROCESSING OF TUMOR INFILTRATING LYMPHOCYTES | Medical technology | Instil Bio, Inc. |
| Sep 26, 2024 | 2024/0319172 | METHODS OF ISOLATING OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF | Analysis of biological materials | Instil Bio, Inc. |
| Aug 15, 2024 | 2024/0269280 | PROCESSING OF TUMOR INFILTRATING LYMPHOCYTES | Medical technology | INSTIL BIO (UK) LIMITED |
| Jun 20, 2024 | 2024/0197785 | PROCESSING OF TUMOR INFILTRATING LYMPHOCYTES | Medical technology | Instil Bio, Inc. |
| Feb 29, 2024 | 2024/0067929 | DEVICES AND METHODS FOR ISOLATING TUMOR INFILTRATING LYMPHOCYTES AND USES THEREOF | Medical technology | INSTIL BIO (UK) LIMITED |
| Feb 22, 2024 | 2024/0058447 | USE OF FUSION CONSTRUCTS FOR IL-2 INDEPENDENT T CELL THERAPY | Medical technology | INSTIL BIO (UK) LIMITED |
| Jan 18, 2024 | 2024/0018476 | DEVICES AND METHODS FOR ISOLATING TUMOR INFILTRATING LYMPHOCYTES AND USES THEREOF | Medical technology | INSTIL BIO (UK) LIMITED |
| Oct 19, 2023 | 2023/0331808 | CHIMERIC MOLECULES PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY | Biotechnology | INSTIL BIO (UK) LIMITED |
| Sep 7, 2023 | 2023/0277670 | CHIMERIC MOLECULES PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY | Biotechnology | INSTIL BIO (UK) LIMITED |
| Jul 27, 2023 | 2023/0235269 | ASEPTIC TISSUE PROCESSING METHOD, KIT AND DEVICE | Biotechnology | INSTIL BIO (UK) LIMITED · patent 12,173,271 granted from it |
What it applied for, 2024 to 2025: Medical technology 6 · Analysis of biological materials 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.